Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
1
x
$
30.00
Theodore J. Anfinson, MD: Drug Dependence Involving Prednisone:Two Cases and a Review of the Literature
1
x
$
30.00
Vilazodone - Safety and Tolerability Profile PB VOL 44 No. 3
1
x
$
30.00
Farmacoterapias: Efectos cardiovasculares y recomendaciones en el uso de psicofarmacos
1
x
$
0.00
Quetiapine XR Negative Clinical Trials Report by Gang Wang
1
x
$
30.00
Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan
1
x
$
30.00
View Cart
Checkout
Home
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
“Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan” has been added to your cart.
View cart
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
$
30.00
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 36 No. 4 Articles
Tags:
antidepressant
,
bipolar-disorder
,
carlos-a-zarate
,
depression
,
felbamate
,
glutamate
,
husseini-k-manji
,
jennifer-payne
,
jorge-quiroz
,
medworks-media
,
memantine
,
mood-stabilizer
,
nmdaampakainate
,
psychopharmacology-bulletin
,
riluzole
Description
Description
Carlos A. Zarate, MD
TRANSLATIONAL NEUROSCIENCE
Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
Carlos A. Zarate, MD, Jorge Quiroz, MD, Jennifer Payne, MD, and Husseini K. Manji, MD
Related products
Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Atomoxetine Induced Hypothermia by Onat Yilmaz
$
30.00
Add to cart
Details
Zonisamide for Bipolar Depression by Deborah Dauphinais
$
30.00
Add to cart
Details
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Page load link
Go to Top